Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alnylam Pharma (DUL) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:DULAlnylam PharmaCHF 138.58CHF 16.87B7.33-39.48%Moderate BuyUnlock the CH:DUL analyst price target with TipRanks PremiumCH:DULUnlock the CH:DUL top-analyst price target with TipRanks Premium
ARWRArrowhead Pharmaceuticals$43.11$6.08B-8.476.52%Strong BuyUnlock the ARWR analyst price target with TipRanks PremiumCH:DUL vs ARWRUnlock the ARWR top-analyst price target with TipRanks Premium
BMRNBioMarin Pharmaceutical$61.43$11.90B-682.5513.42%Moderate BuyUnlock the BMRN analyst price target with TipRanks PremiumCH:DUL vs BMRNUnlock the BMRN top-analyst price target with TipRanks Premium
IONSIonis Pharmaceuticals$27.39$4.49B-8.25-63.23%Strong BuyUnlock the IONS analyst price target with TipRanks PremiumCH:DUL vs IONSUnlock the IONS top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.77$1.37B-2.9215.35%HoldUnlock the NTLA analyst price target with TipRanks PremiumCH:DUL vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
CRSPCrispr Therapeutics AG$40.19$3.90B-8.48-24.84%Moderate BuyUnlock the CRSP analyst price target with TipRanks PremiumCH:DUL vs CRSPUnlock the CRSP top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:DULAlnylam Pharma138.58-90.40-39.48%
ARWRArrowhead Pharmaceuticals43.114.1410.62%
BMRNBioMarin Pharmaceutical61.438.8716.88%
IONSIonis Pharmaceuticals27.39-46.61-62.99%
NTLAIntellia Therapeutics9.771.5318.57%
CRSPCrispr Therapeutics AG40.19-10.54-20.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts